Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Capricor Therapeutics (CAPR) Depreciation and Depletion: 2011-2024

Historic Depreciation and Depletion for Capricor Therapeutics (CAPR) over the last 13 years, with Dec 2024 value amounting to $1.4 million.

  • Capricor Therapeutics' Depreciation and Depletion rose 36.98% to $494,725 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 million, marking a year-over-year increase of 29.85%. This contributed to the annual value of $1.4 million for FY2024, which is 33.34% up from last year.
  • According to the latest figures from FY2024, Capricor Therapeutics' Depreciation and Depletion is $1.4 million, which was up 33.34% from $1.1 million recorded in FY2023.
  • In the past 5 years, Capricor Therapeutics' Depreciation and Depletion ranged from a high of $1.4 million in FY2024 and a low of $139,560 during FY2020.
  • Its 3-year average for Depreciation and Depletion is $1.0 million, with a median of $1.1 million in 2023.
  • Data for Capricor Therapeutics' Depreciation and Depletion shows a peak YoY surged of 118.92% (in 2022) over the last 5 years.
  • Capricor Therapeutics' Depreciation and Depletion (Yearly) stood at $139,560 in 2020, then surged by 74.50% to $243,532 in 2021, then spiked by 118.92% to $533,131 in 2022, then surged by 100.49% to $1.1 million in 2023, then soared by 33.34% to $1.4 million in 2024.